BAILLIE GIFFORD HEALTH INNOVATION EQUITIES FUND

213800AZZVV15BK1K538

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: US-MA
Entity created: December 13, 2021

Address

Country: United States
Legal address: C/O C T CORPORATION SYSTEM, 155 FEDERAL STREET, SUITE 70002110 BOSTONUnited States (US-MA)
Head office: C/O BAILLIE GIFFORD OVERSEAS LIMITED, 3 HAYMARKET SQUAREEH3 8RY EDINBURGHUnited Kingdom (GB-EDH)

Identifier

LEI: 213800AZZVV15BK1K538
Registered: December 13, 2021 at 12:00 AM UTC
Last updated: July 3, 2026 at 08:50 AM UTC
Next renewal: September 13, 2026 at 12:00 AM UTC
Issuer: London Stock Exchange (213800WAVVOPS85N2205)
Registered with: EDGAR (RA000665)
Identifier: S000074799
Verified against: EDGAR (RA000665)
Verified as: S000074799
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

BAILLIE GIFFORD OVERSEAS LIMITED
Fund managerUnited Kingdom549300OJXEENXLO4FW52
BAILLIE GIFFORD FUNDS
Umbrella fundUnited States213800T287IYS8QHPC42

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/213800AZZVV15BK1K538This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search